NCT06651775 Effectiveness of High Intensity Laser Therapy (HILT) in Patients With Chronic Lumbar Radiculopathy Due to Disc Herniation.
| NCT ID | NCT06651775 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara City Hospital Bilkent |
| Condition | Lumbar Radiculopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-05-15 |
| Primary Completion | 2025-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-05-15 with a primary completion date of 2025-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the researchers in this intervention study was to see the effects of High Intensity Laser Therapy (HILT) on participants' disability, functionality and pain parameters in chronic radicular low back pain due to lumbar disc herniation, and to investigate its superiority over widely used conventional electrotherapy modalities. The main question it aims to answer is: What is the short and long term effect of high intensity laser therapy on low back and leg pain in patients with chronic lumbar radiculopathy due to disc herniation? 35 patients in group A will receive the planned Hotpack, TENS, High Intensity Laser Therapy (HILT) and exercise treatments for lumbar radicular low back pain. In group B (comparison group) 35 patients will receive Hotpack, TENS, sham HILT, and exercise treatments. Participants will receive 15 sessions of treatment and exercises will be given as a home program. Both groups will complete questionnaires about disability, life functions and pain before and after treatment and at the 3rd month follow-up.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with lumbar radiculopathy due to lumbar disc herniation and whose complaints are correlated with lumbar MRI * Patients aged 18-65 years * Patients who agreed to participate in the study * Literate patients Exclusion Criteria: * Pregnancy * Patients with cardiac pacemakers * Patients with a diagnosis of inflammatory rheumatic disease, * Patients with a diagnosis of polyneuropathy that precludes receiving treatment, * Patients with active or history of malignancy within the last 1 year and currently receiving chemotherapy and/or radiotherapy, * Patients with serious psychiatric illness, * Patients with severe coagulation disorders, * Spinal Stenosis (patients with spinal canal diameter less than 8 mm) * Patients with neurologic deficits that prevent them from receiving treatment, * Patients with active infection, * Patients with vasculitis, * Patients with skin disease in the treated area, * Patients who received steroid injections and/or physical therapy for the lumbar region within the last 3 months, * Patients undergoing lumbar spine surgery, * Patients with acute trauma, * Patients with a history of lumbar instability, * Patients with uncontrolled or severe cardiovascular or metabolic disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06651775 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Lumbar Radiculopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06651775 currently recruiting?
Yes, NCT06651775 is actively recruiting participants. Contact the research team at drberkearas@gmail.com for enrollment information.
Where is the NCT06651775 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06651775 clinical trial?
NCT06651775 is sponsored by Ankara City Hospital Bilkent. The trial plans to enroll 70 participants.